<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">317</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 469.160 L116.350 469.160 "/>
  <g begin="text">
   <text y="76.959" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="76.959" x="101.287,109.063,113.059,115.489,119.485,123.985,127.981,130.483,134.983,138.484,142.48,146.98,149.41,151.912,156.412,160.408,162.838,165.34,169.84,173.836,177.832,180.334,182.836,186.832,190.828,193.33,195.832,200.332,204.832,207.262,211.762,214.759,217.189,221.689,225.685,230.185,232.615,236.611,241.111,248.113,252.613,255.115,259.111,266.113,270.109,274.609,277.111,279.541,283.537,288.037,295.039" svgx:width="0.94,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We analysed the localization of key complement com-</text>
   <text y="87.957" x="62.362,66.862,71.362,75.862,79.858,84.358,86.86,90.361,92.512,96.508,101.008,105.508,107.659,110.656,114.652,119.152,123.652,126.154,130.15,132.652,137.152,140.149,143.65,145.801,148.303,152.803,154.954,159.454,163.954,167.455,169.957,172.954,179.956,184.456,187.453,189.955,193.951,200.953,203.104,207.604,210.601,214.597,217.099,221.599,225.1,227.602,231.598,238.6,240.751,243.253,245.755,249.256,252.757,257.257,261.253,263.395,266.392,269.389,273.889,280.891,283.042,287.542,290.539,295.039" svgx:width="0.5,0.5,0.5,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.28,0.5,0.25,0.5,0.5,0.39,0.28,0.33,0.78,0.5,0.33,0.28,0.44,0.78,0.25,0.5,0.33,0.44,0.28,0.5,0.39,0.28,0.44,0.78,0.25,0.28,0.28,0.39,0.39,0.5,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ponents and regulators in post-mortem brainstem tissue from pro-</text>
   <text y="98.955" x="62.362,66.862,69.859,73.855,77.356,80.857,83.359,87.859,91.855,93.556,100.558,105.058,107.56,110.062,112.564,117.064,119.566,123.562,125.263,128.764,132.76,135.262,139.258,142.255,146.755,150.256,152.758,156.259,157.96,162.46,166.96,171.46,175.96,178.957,182.458,184.708,186.409,188.911,193.411,195.112,198.109,202.105,204.607,208.603,211.105,213.607,218.107,222.607,224.308,226.81,231.31,233.011,237.511,241.507,246.007,249.004,253.504,258.004,262.0,264.502,269.002,273.502,276.004,280.504,285.004,287.506,291.502,295.498,298.0" svgx:width="0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.5,0.5,0.5,0.33,0.39,0.25,0.25,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gressive multiple sclerosis donors, in relation to neuropathological </text>
   <text y="109.953" x="62.362,66.358,70.858,74.854,79.354,83.854,87.85,91.351,93.601,95.869,99.865,104.365,108.865,111.133,115.129,119.629,126.631,131.131,135.127,138.124,142.12,146.62,148.888,151.39,155.89,159.886,162.154,165.151,167.653,172.153,176.653,179.155,183.655,188.155,191.656,193.924,196.426,200.926,203.194,207.694,210.691,214.687,217.189,221.689,225.19,227.692,231.688,238.69,240.958,243.46,245.962,249.463,252.964,257.464,261.46,263.728,268.228,271.225,273.493,277.993,282.493,286.993,291.493,294.49,297.991" svgx:width="0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.25,0.5,0.33,0.44,0.28,0.5,0.39,0.28,0.44,0.78,0.25,0.28,0.28,0.39,0.39,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.5,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">changes, and compared the findings to brainstem tissue of donors </text>
   <text y="120.951" x="62.362,68.86,71.362,73.864,78.364,80.614,82.774,87.274,89.776,94.276,98.272,101.269,103.519,105.679,110.179,114.175,118.675,121.672,126.172,128.674,133.174,137.674,140.176,144.172,148.168,150.67,152.92,155.08,159.58,162.082,165.583,169.579,173.575,177.076,181.072,184.573,186.823,188.983,193.483,196.48,198.73,200.89,205.39,209.89,214.39,217.387,221.887,225.883,230.383,233.38,237.88,240.382,244.882,249.382,251.884,255.88,259.876,262.378,264.628,266.788,270.784,275.284,279.784,282.286,285.283,289.783,292.285,295.786,298.036" svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.33,0.5,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with other neurological diseases or non-neurological controls. </text>
   <text y="131.949" x="62.362,68.365,72.865,79.867,84.367,86.869,90.865,97.867,101.863,106.363,108.865,111.115,112.366,115.363,119.863,124.363,128.359,130.861,133.363,137.863,142.363,144.613,145.864,152.362,156.358,159.859,162.109,163.36,165.862,169.858,173.359,175.861,179.857,184.357" svgx:width="0.67,0.5,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.44,0.39,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Complement function was tested </text>
   <text y="131.949" x="187.858,190.36,194.86,197.11,198.361,202.357,204.859,207.361,210.529" svgx:width="0.28,0.5,0.25,0.55,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="131.949" x="215.029,217.279,218.53,223.03,226.531,229.033,233.533,238.033,240.283,241.534,246.034,249.031,251.533,258.535,262.531,265.528,270.028,272.278,273.529,278.029,282.529,289.531,293.527,298.027" svgx:width="0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.55,0.5,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> using primary human </text>
   <text y="142.947" x="62.362,66.358,69.859,72.361,75.358,79.858,83.854,88.354,90.856,94.852,98.353,100.603,103.204,107.2,111.7,116.2" svgx:width="0.44,0.39,0.28,0.33,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">astrocytes, and </text>
   <text y="142.947" x="118.801,121.303,125.803,128.404,132.4,134.902,138.898" svgx:width="0.28,0.5,0.25,0.44,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vivo</text>
   <text y="142.947" x="143.398,145.999,150.499,154.0,156.502,161.002,165.502,168.103,175.105,177.607,181.603,185.599,188.2,194.698,197.2,199.702,204.202,206.803,211.303,215.299,219.799,223.795,226.297,228.799,232.795,235.396,239.896,242.893,245.494,249.994,254.494,258.49,261.487,268.489,272.485,276.481,280.981,283.483,287.983,292.483,294.985" svgx:width="0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.78,0.28,0.44,0.44,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.28,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> using mice with genetic or pharmacologi-</text>
   <text y="153.945" x="62.362,66.358,70.354,72.856,75.106,77.608,82.108,86.608,89.11,93.61,96.112,98.614,101.116,105.616,110.116,112.366,116.866,119.863,122.113,126.613,130.609,135.109,137.359,141.355,145.855,152.857,157.357,159.859,163.855,170.857,174.853,179.353,181.855,184.105,188.101,192.601,199.603,204.103,208.603,213.103,217.099,221.599,224.101,227.602" svgx:width="0.44,0.44,0.28,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cal inhibition of key complement components.</text>
   <text y="164.943" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="164.943" x="96.058,103.834,107.83,110.53,115.03,119.026,121.528,125.524,129.52,132.022,136.018,140.518,143.218,146.719,151.219,155.719,159.22,161.722,165.718,170.218,172.72,175.222,179.218,181.72,184.42,188.92,192.916,197.416,201.916,205.417,207.919,210.421,212.923,217.423,221.923,224.623,229.123,232.12,234.82,238.816,243.316,250.318,254.818,257.32,261.316,268.318,272.314,276.814,279.316,282.016,286.012,290.008,292.51,295.012" svgx:width="0.94,0.44,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.39,0.5,0.5,0.39,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.25,0.44,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We detected substantial deposition of complement acti-</text>
   <text y="175.941" x="62.362,66.862,70.858,73.36,75.862,80.362,84.862,87.112,88.759,93.259,96.256,100.756,105.256,109.756,113.752,116.254,119.755,122.005,123.652,128.152,132.652,134.902,136.549,141.049,145.045,149.545,152.542,157.042,161.542,165.043,167.293,169.543,171.19,175.186,179.686,184.186,188.686,192.187,194.437,196.687,198.334,201.835,206.335,210.835,214.831,219.331,222.832,226.828,230.329,232.579,234.226,238.222,242.722,247.222,249.472,251.119,255.115,258.616,261.118,264.115,268.615,272.611,277.111,279.613,283.609,287.11,289.36,291.007,293.509,298.009" svgx:width="0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.5,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.25,0.25,0.55,0.39,0.5,0.5,0.44,0.5,0.39,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.39,0.28,0.33,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vation products on neurons, axons, synapses and astrocytes in </text>
   <text y="186.939" x="62.362,66.862,71.362,78.364,82.36,86.86,89.11,91.018,95.518,98.515,102.511,105.013,109.513,113.014,115.516,119.512,126.514,128.764,131.014,132.922,139.42,143.416,147.916,150.913,155.413,159.913,163.414,165.664,167.572,172.072,176.572,179.569,182.566,186.562,191.062,195.562,198.064,202.06,204.562,208.558,213.058,215.308,217.216,220.717,223.219,226.216,230.212,233.713,237.214,239.464,241.372,248.374,252.37,255.367,259.867,263.863,266.86,270.361,272.863,275.113,277.021,281.017,285.517,290.017,294.517,298.018" svgx:width="0.5,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.39,0.28,0.44,0.78,0.25,0.25,0.55,0.72,0.44,0.5,0.33,0.5,0.5,0.39,0.25,0.55,0.5,0.5,0.33,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.39,0.28,0.33,0.44,0.39,0.39,0.25,0.55,0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.28,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">human brainstem. Neurons up-regulated stress markers; axons </text>
   <text y="197.937" x="62.362,65.863,70.363,74.863,81.361,85.357,89.857,92.107,94.348,98.848,101.35,104.851,107.353,111.853,114.85,119.35,123.346,127.846,130.096,132.337,135.334,139.33,142.831,145.333,147.583,149.824,152.326,155.323,159.319,163.819,167.32,171.82,176.32,179.317,181.819,184.069,186.31,190.306,194.806,199.306,201.556,203.797,206.299,210.799,214.3,216.802,219.052,221.293,224.794,229.294,233.794,237.79,242.29,245.791,249.787,253.288,255.538,257.788,259.534,266.032,269.533,272.035,275.032,279.532,283.528,288.028,290.53,294.526,298.027" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.28,0.5,0.33,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.39,0.28,0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.5,0.5,0.33,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.39,0.28,0.25,0.55,0.39,0.5,0.5,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.72,0.39,0.28,0.33,0.5,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed disturbed fast transport and lost synapses. Astrocytes </text>
   <text y="208.935" x="62.362,68.86,72.856,75.853,79.849,82.09,86.59,91.09,94.591,97.093,99.595,102.097,106.597,110.593,112.834,115.831,120.331,123.328,125.569,130.069,133.066,137.566,140.563,143.065,147.565,150.562,153.064,157.06,164.062,171.064,175.06,177.562,182.062,185.059,189.559,191.8,195.796,200.296,202.798,207.298,211.798,214.3,218.8,222.796,226.297,228.547,230.788,236.791,241.291,245.791,248.032,252.028,256.528,261.028,263.269,269.272,273.772,278.272,280.513,287.011,291.007,294.004,298.0" svgx:width="0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.25,0.67,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.67,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were positive for pro-inflammatory cytokines. C1q and C3d were </text>
   <text y="219.933" x="62.362,66.862,70.858,73.36,77.356,81.352,83.854,87.85,92.35,94.6,95.752,100.252,104.752,107.002,108.154,112.654,116.65,121.15,124.147,128.647,133.147,136.648,138.898,141.148,142.3,146.296,150.796,155.296,159.796,163.297,165.547,166.699,170.695,175.195,179.695,181.945,183.097,186.598,191.098,195.598,199.594,204.094,207.595,211.591,215.092,217.342,219.592,220.744,227.242,231.742,235.738,238.735,242.731,246.727,250.228,252.478,253.63,256.132,260.632,264.628,266.878,268.03,270.532,274.528,277.525,284.527,287.029,291.529,295.525,298.027" svgx:width="0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.5,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">detected on neurons, axons and synapses, whereas the terminal </text>
   <text y="230.931" x="62.362,66.358,70.354,72.856,75.358,79.858,83.854,86.356,88.858,93.358,97.858,100.108,101.062,105.562,108.559,113.059,117.559,122.059,126.055,128.557,130.807,133.057,134.011,141.013,145.009,152.011,156.511,159.508,163.504,168.004,172.0,174.25,175.204,179.2,181.702,184.204,188.2,192.196,196.696,198.946,199.9,203.896,208.396,215.398,219.898,222.4,226.396,230.896,233.146,234.1,237.097,245.098,251.596,257.599,260.596,262.846,265.096,266.05,270.046,274.546,277.543,280.045,284.545,288.541,292.537,295.039" svgx:width="0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.25,0.25,0.55,0.78,0.44,0.78,0.5,0.33,0.44,0.5,0.44,0.25,0.55,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.5,0.25,0.55,0.33,0.89,0.72,0.67,0.33,0.25,0.25,0.55,0.44,0.5,0.33,0.28,0.5,0.44,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">activation product, membrane attack complex (MAC), co-local-</text>
   <text y="241.929" x="62.362,64.864,68.86,72.856,77.356,79.318,83.818,88.318,90.28,94.276,97.777,100.279,103.276,107.776,111.772,116.272,118.774,122.77,126.271,128.233,132.733,137.233,140.734,143.236,145.738,148.24,152.74,156.736,158.698,161.695,166.195,169.192,171.154,173.656,178.156,180.658,184.654,187.651,190.153,194.149,198.649,203.149,205.651,210.151,212.113,216.613,218.575,223.075,227.071,229.573,233.569,235.531,238.528,241.525,247.024,250.021,254.521,259.102,262.099,264.061,266.563,271.063,273.025,275.527,279.523,283.024,285.526,290.026,294.526,298.027" svgx:width="0.28,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.39,0.28,0.33,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.33,0.28,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.25,0.5,0.44,0.28,0.44,0.25,0.33,0.33,0.61,0.33,0.5,0.51,0.33,0.25,0.28,0.5,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ized on astrocytes positive for interleukin 1 beta (IL-1β) in lesions </text>
   <text y="252.927" x="62.362,66.358,70.858,75.358,77.527,80.029,84.529,89.029,93.529,97.525,101.521,106.021,108.19,112.69,115.687,120.187,123.184,125.686,130.186,133.183,135.685,139.681,146.683,153.685,157.681,160.183,164.683,167.68,172.18,174.349,178.345,182.845,185.347,189.847,194.347,196.849,201.349,205.345,208.846,211.015,213.517,218.017,220.186,224.686,229.186,236.188,240.184,244.684,246.853,251.353,254.35,256.852,263.854,267.85,270.847,275.347,277.516,281.512,285.013,287.515,290.512,295.012" svgx:width="0.44,0.5,0.5,0.25,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.5,0.78,0.44,0.5,0.25,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.44,0.39,0.28,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and induced pro-inflammatory cytokines in human primary astro-</text>
   <text y="263.925" x="62.362,66.358,70.858,73.36,77.356,80.857,83.107,85.285,91.783,95.779,100.279,103.276,107.776,112.276,115.777,117.955,124.453,128.449,131.446,135.442,137.62,141.121,143.623,146.62,151.12,155.62,160.12,162.622,167.122,169.3,173.8,178.3,181.801,184.303,186.805,189.307,193.807,197.803,199.981,202.978,207.478,210.475,212.653,215.155,219.655,223.651,225.829,229.825,234.325,241.327,245.827,248.329,252.325,259.327,263.323,267.823,270.325,272.503,275.5,279.496,283.996,288.496,290.998,294.994" svgx:width="0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.5,0.33,0.5,0.5,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.28,0.33,0.5,0.5,0.5,0.28,0.5,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytes. Neurons were strongly positive for the complement regula-</text>
   <text y="274.923" x="62.362,64.864,69.364,72.361,76.861,79.111,80.407,84.907,87.904,92.404,94.906,98.902,101.404,105.904,108.154,109.45,115.453,121.951,126.451,130.951,133.201,134.497,138.997,143.497,145.999,148.249,149.545,152.047,156.547,160.048,162.55,164.8,166.096,170.092,174.592,179.092,182.089,186.085,189.586,193.087,195.589,200.089,204.589,206.839,208.135,212.635,215.632,217.882,219.178,225.181,231.679,236.179,240.679,242.929,244.225,250.723,253.225,255.727,260.227,262.729,267.229,269.479,270.775,273.277,277.273,280.774,283.276,287.776,292.276,295.777,298.027" svgx:width="0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.39,0.28,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.28,0.5,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tory protein CD59 but lost expression of CD55 within lesions. </text>
   <text y="285.921" x="62.362,67.366,71.866,74.863,77.365,81.865,85.861,88.498,90.748,93.529,98.029,101.53,104.032,108.532,113.032,115.813,122.815,125.317,129.313,133.309,136.09,140.59,144.586,149.086,153.082,155.584,158.086,162.082,166.078,168.58,171.082,175.582,178.363,182.863,186.859,189.856,192.358,196.354,198.856,202.852,207.352,209.854,212.635,215.137,219.637,222.418,228.421,234.919,239.419,243.919,246.7,251.2,254.197,256.978,262.981,269.479,273.979,278.479,282.475,284.725,287.506,294.004,298.0" svgx:width="0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.78,0.28,0.44,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.67,0.72,0.5,0.5,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.5,0.44,0.25,0.25,0.72,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Further, using mice genetically deficient in CD55 or CD59a, we </text>
   <text y="296.919" x="62.362,65.359,69.859,74.359,78.859,83.359,85.654,88.156,92.656,96.652,99.154,101.449,104.446,108.442,112.942,117.442,119.944,123.94,126.442,128.944,133.444,137.944,140.239,144.739,147.736,150.031,152.533,157.033,161.029,163.324,165.826,169.822,172.819,179.821,182.323,186.823,190.819,193.321,195.616,199.612,204.112,211.114,215.614,218.116,222.112,229.114,233.11,237.61,240.112,242.407,246.907,250.903,253.405,257.905,264.403,268.399,272.899,275.194,277.696,281.197,283.492,287.488,290.485,294.985" svgx:width="0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.28,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.28,0.39,0.25,0.44,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">found that regulation of the terminal complement pathway is cru-</text>
   <text y="307.917" x="62.362,66.358,68.86,72.856,75.358,77.185,79.687,84.187,86.014,90.514,93.511,98.011,100.513,104.509,108.505,111.007,112.834,115.831,118.828,123.328,130.33,132.157,140.158,146.656,152.659,154.486,158.986,162.982,167.482,171.982,175.483,177.985,180.487,182.989,187.489,191.989,193.816,198.316,202.816,204.643,209.143,213.139,217.639,220.636,225.136,229.636,233.137,235.387,237.214,240.715,245.215,249.715,253.216,257.212,261.712,266.212,270.208,274.708,277.21,279.037,283.033,285.535,288.037,292.537,295.039" svgx:width="0.44,0.28,0.44,0.28,0.25,0.28,0.5,0.25,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.33,0.5,0.78,0.25,0.89,0.72,0.67,0.25,0.5,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.39,0.25,0.25,0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.44,0.28,0.28,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cial to protect from MAC deposition on neurons, subsequent clini-</text>
   <text y="318.915" x="62.362,66.358,70.354,72.856,74.593,79.093,81.595,85.096,89.092,93.592,96.094,98.596,101.098,103.6,108.1,109.837,113.833,118.333,122.833,124.57,129.07,133.066,137.566,140.563,145.063,149.563,153.559,156.061,160.561,165.061,167.563,172.063,176.563,181.063,182.8,185.302,189.802,191.539,194.041,198.541,202.537,204.274,208.27,212.77,217.27,221.266,224.263,226.765,233.767,237.763,242.263,244.765,248.761,251.263,253.0,256.996,261.496,263.998,268.498,271.0,278.002,285.004,289.504,294.004,298.0" svgx:width="0.44,0.44,0.28,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cal disability and neuropathology in the experimental autoimmune </text>
   <text y="329.913" x="62.362,66.358,70.858,74.854,78.85,83.35,87.85,91.846,94.348,98.848,105.85,110.35,114.346,116.848,119.35,121.852,124.354,127.855,130.10500000000002,131.239,134.236,139.735,146.233,151.732,154.729,156.979,158.113,165.115,169.615,174.115,178.111,180.613,182.863,183.997,188.497,191.494,193.744,194.878,202.879,207.883,210.133,212.383,213.517,216.514,221.014,223.264,224.398,228.394,232.894,237.394,239.896,242.398,244.9,249.4,253.9,256.15,258.4,259.534,264.034,268.534,272.53,275.527,282.529,286.525,290.521,295.021" svgx:width="0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.33,0.61,0.72,0.61,0.33,0.25,0.55,0.78,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.56,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">encephalomyelitis (EAE) model of MS. In addition, pharmaco-</text>
   <text y="340.911" x="62.362,64.864,69.364,73.864,76.366,80.362,84.358,86.86,89.326,91.828,96.328,100.828,103.33,107.83,110.332,112.834,115.336,119.836,124.336,126.802,131.302,134.299,136.765,139.267,143.767,147.763,150.229,158.23,164.728,170.731,173.197,175.699,180.199,182.665,189.163,191.665,194.167,198.667,201.664,204.166,208.666,213.166,217.162,219.628,226.63,229.132,233.128,237.124,239.59,244.09,247.087,251.083,255.583,259.579,264.079,266.581,270.577,275.077,277.543,281.539,285.04,287.542,290.539,295.039" svgx:width="0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.89,0.72,0.67,0.25,0.28,0.5,0.25,0.72,0.28,0.28,0.5,0.33,0.28,0.5,0.5,0.44,0.25,0.78,0.28,0.44,0.44,0.25,0.5,0.33,0.44,0.5,0.44,0.5,0.28,0.44,0.5,0.25,0.44,0.39,0.28,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">logical inhibition of the MAC in wild-type mice prevented astro-</text>
   <text y="351.909" x="62.362,66.358,70.858,73.36,77.356,79.561,83.557,87.553,90.055,92.557,97.057,101.053,103.555,106.057,110.557,115.057,117.262,121.258,125.758,130.258,132.463,136.963,140.959,145.459,148.456,152.956,157.456,161.452,163.954,166.159,170.659,174.655,181.657,185.653,190.153,194.149,196.399,198.604,202.105,206.605,211.105,215.605,218.602,222.598,226.099,229.6,232.102,236.602,241.102,243.307,247.303,249.805,252.307,256.807,259.309,263.305,267.301,269.803,272.008,276.508,279.01,282.511,286.507,290.503,294.004,298.0" svgx:width="0.44,0.5,0.28,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.25,0.5,0.44,0.78,0.44,0.5,0.44,0.25,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cyte activation and neuronal damage, suppressing clinical disease </text>
   <text y="362.907" x="62.362,66.358,70.858,75.358,77.608,82.108,86.104,88.606,93.106,97.606,100.108,104.608,109.108,113.608,115.858,118.36,122.86,125.11,130.609,137.107,142.606" svgx:width="0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.61,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and pathology in EAE.</text>
   <text y="373.905" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="373.905" x="115.318,121.816,126.316,129.313,131.563,132.76,135.757,138.259,142.759,147.259,149.761,154.261,158.761,162.262,164.512,165.709,168.211,172.711,177.211,179.713,183.709,187.705,190.207,194.203,196.453,197.65,200.152,204.652,208.648,211.15,213.4,214.597,218.593,223.093,230.095,234.595,237.097,241.093,248.095,252.091,256.591,259.093,261.343,262.54,266.536,270.532,273.034,275.536,280.036,284.032,286.534,289.036,293.536,298.036" svgx:width="0.72,0.5,0.33,0.25,0.55,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our findings indicate that complement activation </text>
   <text y="384.903" x="62.362,66.862,70.858,74.854,79.354,82.351,85.852,88.327,90.829,95.329,97.804,105.805,110.809,113.284,117.784,120.781,124.777,129.277,131.752,138.754,142.75,145.252,147.754,151.75,154.747,157.222,161.218,165.718,170.218,172.693,177.193,179.695,183.691,188.191,191.692,194.167,198.163,200.638,205.138,209.134,213.634,216.109,219.106,223.606,226.108,230.104,232.579,235.081,239.581,242.056,246.556,250.552,255.052,258.049,262.549,267.049,271.045,275.545,279.541,284.041,288.037,291.034,295.03" svgx:width="0.5,0.44,0.44,0.5,0.33,0.39,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.33,0.44,0.5,0.25,0.78,0.44,0.28,0.28,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.5,0.39,0.25,0.44,0.25,0.5,0.44,0.5,0.25,0.33,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.5,0.44,0.5,0.44,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">occurs in MS grey matter and plays a key role in neurodegenera-</text>
   <text y="395.901" x="62.362,64.864,67.366,71.866,76.366,78.616,81.118,85.618,87.868,94.87,99.37,103.87,107.866,110.368,113.869,116.119,120.115,124.615,129.115,131.365,138.367,142.363,146.863" svgx:width="0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.78,0.5,0.5,0.44,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion in models and man.</text>
   <text y="423.9" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P564</text>
   <text y="434.898" x="62.362,65.863,70.867,73.864,77.86,82.36,85.357,90.361,94.357,98.353,102.853,105.355,107.605,113.608,118.612,122.113,125.11,129.106,131.608,136.612,139.609,145.612,150.112,154.108,158.104,160.354,164.854,167.356,171.352,176.356,179.857,182.107,185.608,190.612,194.608,198.604,201.106,204.103,206.605,210.601,212.851,219.349,225.847,230.347,232.597,238.6,241.597,245.593,249.589,252.091,254.593" svgx:width="0.39,0.56,0.33,0.44,0.5,0.33,0.56,0.44,0.44,0.5,0.28,0.25,0.67,0.56,0.39,0.33,0.44,0.28,0.56,0.33,0.67,0.5,0.44,0.44,0.25,0.5,0.28,0.44,0.56,0.39,0.25,0.39,0.56,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.72,0.72,0.5,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Intrathecal Epstein-Barr virus specific CD8 T-cell </text>
   <text y="445.896" x="62.362,66.358,70.354,73.855,78.859,83.359,88.363,91.864,95.86,99.361,101.611,104.113,109.117,111.367,118.864,123.868,126.37,129.367,131.869,136.873,139.375,143.371,145.621,149.122,153.118,155.62,159.616,163.612,168.112,171.613,174.115,177.616,179.866,184.87,189.37,192.367,194.869,198.865,203.869,206.866,210.367,212.617,217.117,221.113,225.109,227.359,232.363,234.865,238.861,242.857,246.853,249.85,253.846,258.85,261.1,264.097,268.597" svgx:width="0.44,0.44,0.39,0.56,0.5,0.56,0.39,0.44,0.39,0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.5,0.44,0.44,0.25,0.56,0.28,0.44,0.44,0.44,0.33,0.44,0.56,0.25,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">responses in multiple sclerosis patients are directed to </text>
   <text y="456.894" x="62.362,64.864,69.364,72.361,74.863,78.859,81.109,85.609,88.111,92.107,96.607,99.109,101.359,105.859,110.863,113.86,116.362,120.862,124.858,129.862" svgx:width="0.28,0.5,0.33,0.28,0.44,0.25,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.56,0.33,0.28,0.5,0.44,0.56,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">lytic viral antigens</text>
   <text y="467.892" x="62.362,68.86,73.864,76.114,80.614,84.61,89.11,91.36,97.858,100.36,104.356,107.353,111.853" svgx:width="0.72,0.56,0.25,0.5,0.44,0.5,0.25,0.72,0.28,0.44,0.33,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">GP van Nierop</text>
   <text y="465.439" x="116.353,119.278,120.74" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="467.959" x="123.665,125.915,128.165,131.666,138.164,140.414,148.415,150.917,153.419,155.921,159.917,162.914,165.911,169.907,172.409,174.911,178.907" svgx:width="0.25,0.25,0.39,0.72,0.25,0.89,0.28,0.28,0.28,0.44,0.33,0.33,0.44,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JG Mitterreiter</text>
   <text y="465.439" x="181.903" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.959" x="184.828,187.078,189.328,195.331,200.83,203.08,209.578,213.574,217.57,222.07,229.072,233.068,237.568" svgx:width="0.25,0.25,0.67,0.61,0.25,0.72,0.44,0.44,0.5,0.78,0.44,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, BL Haagmans</text>
   <text y="465.439" x="241.068" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.959" x="243.993,246.243,248.493,251.995" svgx:width="0.25,0.25,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J </text>
   <text y="478.957" x="62.365,70.366,74.362,78.862,81.364,85.864,89.86" svgx:width="0.89,0.44,0.5,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Mautner</text>
   <text y="476.439" x="92.854" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="478.959" x="95.779,98.029,100.279,106.777,113.275,121.276,126.775,129.025,135.523,139.024,141.526,145.522,148.519,153.019,157.015,161.515" svgx:width="0.25,0.25,0.72,0.72,0.89,0.61,0.25,0.72,0.39,0.28,0.44,0.33,0.5,0.44,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, ADME Osterhaus</text>
   <text y="476.439" x="165.015" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.959" x="167.94,170.19,172.44,178.443,184.941,187.191,193.689,196.191,200.691,203.193,207.189,211.185" svgx:width="0.25,0.25,0.67,0.72,0.25,0.72,0.28,0.5,0.28,0.44,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, RQ Hintzen</text>
   <text y="476.439" x="215.684" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="478.959" x="218.609,220.859,223.109,229.607,237.608,244.106,252.107,254.357,260.855,264.851,267.848,270.35,274.346,278.846" svgx:width="0.25,0.25,0.72,0.89,0.72,0.89,0.25,0.72,0.44,0.33,0.28,0.44,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, GMGM Verjans</text>
   <text y="476.439" x="282.346" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="487.437" x="62.363" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.959" x="65.287,70.786,74.287,78.787,82.288,88.786,93.286,96.787,99.037,106.534,112.537,114.787,117.037,122.536,125.038,128.539,133.039,136.54,140.536,143.038,147.034,151.534,155.53,159.526,161.776,164.026,169.525,174.025,176.527,179.029,183.025,186.526,191.026,195.526,202.024,204.274,206.524,212.527,216.523,219.025,223.525,227.521,231.022,233.524,238.024,242.524,247.024,250.525,252.775" svgx:width="0.61,0.39,0.5,0.39,0.72,0.5,0.39,0.25,0.83,0.67,0.25,0.25,0.61,0.28,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25,0.61,0.5,0.28,0.28,0.44,0.39,0.5,0.5,0.72,0.25,0.25,0.67,0.44,0.28,0.5,0.44,0.39,0.28,0.5,0.5,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Erasmus MC, Viroscience, Rotterdam, Netherlands, </text>
   <text y="487.439" x="255.023" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="489.959" x="257.948,263.447,266.948,271.448,274.949,281.447,285.947,289.448" svgx:width="0.61,0.39,0.5,0.39,0.72,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Erasmus </text>
   <text y="500.957" x="62.36,69.857,75.86,78.11,80.351,85.85,89.351,93.851,97.352,104.849,109.349,111.59,117.593,121.589,126.089,128.591,132.092,136.088,138.329,142.829,145.331,147.572,150.074,154.574,158.57,160.811,167.309,171.305,175.805,180.305,183.806,186.308,192.806,196.802,201.302,203.804,206.045,210.545,213.047,215.288,221.291,225.287,229.787,233.288,237.788,240.29,244.79,249.29,253.286,255.536,257.777,263.276,267.776,270.278,272.78,276.776,280.277,284.777,289.277,295.775,298.025" svgx:width="0.83,0.67,0.25,0.25,0.61,0.39,0.5,0.39,0.83,0.5,0.25,0.67,0.44,0.5,0.28,0.39,0.44,0.25,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.5,0.28,0.28,0.44,0.39,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MC, ErasMS Centre at the Department of Neurology, Rotterdam, </text>
   <text y="511.955" x="62.36,68.363,72.359,74.861,79.361,83.357,86.858,89.36,93.86,98.36,102.86,106.361,108.611" svgx:width="0.67,0.44,0.28,0.5,0.44,0.39,0.28,0.5,0.5,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Netherlands, </text>
   <text y="509.439" x="110.863" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="511.959" x="113.788,120.286,124.282,126.784,133.282,137.782,142.282,144.784,147.286,150.787,153.784,158.788,162.784,167.284,169.786,173.287,177.787,184.285,186.535,188.785,194.788,197.29,199.792,204.292,206.794,210.79,215.29,217.792,220.042,226.045,230.545,235.045,239.545,243.541,247.042,251.542,254.044,256.546,261.046,265.546,267.796,274.294,277.795,282.295,286.795,291.295,293.545" svgx:width="0.72,0.44,0.28,0.72,0.5,0.5,0.28,0.28,0.39,0.33,0.56,0.44,0.5,0.28,0.39,0.5,0.72,0.25,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.5,0.5,0.5,0.44,0.39,0.5,0.28,0.28,0.5,0.5,0.25,0.72,0.39,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Helmholtz-Zentrum, Clinical Cooperation Group, </text>
   <text y="522.957" x="62.362,67.861,71.857,76.357,78.859,83.359,85.861,89.362,91.864,95.86,98.11,103.114,107.614,114.112,118.612,122.113,124.363,127.36,133.858,140.356,144.856,149.356,153.856,156.358,160.858,165.358,169.354,171.604,173.854,181.351,185.851,190.351,194.347,198.847,202.843,207.343,209.593,211.843,218.341,222.337,225.838,232.336,236.836,241.336" svgx:width="0.61,0.44,0.5,0.28,0.5,0.28,0.39,0.28,0.44,0.25,0.56,0.5,0.72,0.5,0.39,0.25,0.33,0.72,0.72,0.5,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Pediatric Tumor Immunology, München, Germany</text>
   <text y="549.957" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="549.957" x="115.831,121.33,125.83,129.331,131.833,135.829,138.331,142.831,145.828,151.831,155.827,158.824,161.821,164.071,164.944,169.444,171.946,174.943,179.443,182.944,185.194,186.067,189.064,194.563,200.566,207.064,210.061,212.311,213.184,215.686,220.186,223.183,227.179,231.175,233.677,236.179,240.679,245.179,247.429,248.302,250.804,254.305,256.555,257.428,261.424,263.674,264.547,268.543,272.539,277.039,280.54,284.536,287.038,289.54,294.04,298.036" svgx:width="0.61,0.5,0.39,0.28,0.44,0.28,0.5,0.33,0.67,0.44,0.33,0.33,0.25,0.55,0.5,0.28,0.33,0.5,0.39,0.25,0.55,0.33,0.61,0.67,0.72,0.33,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.44,0.44,0.5,0.39,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Epstein-Barr virus (EBV) infection is a causative </text>
   <text y="560.955" x="62.362,65.359,67.861,71.362,75.862,78.337,81.334,85.33,89.326,91.828,96.328,99.325,101.8,104.797,109.297,112.294,114.769,122.77,127.774,130.024,132.499,138.997,143.497,147.493,150.49,152.992,155.467,160.966,166.969,172.639,175.636,179.137,183.637,187.633,191.629,194.131,197.128,199.63,203.626,206.101,208.603,215.605,222.607,227.107,231.607,235.603,238.078,241.075,245.071,248.572,253.072,257.572,262.072,265.573,269.569,273.07,275.545,278.047,282.547,285.022,293.023,298.027" svgx:width="0.33,0.28,0.39,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.89,0.56,0.25,0.25,0.72,0.5,0.44,0.33,0.28,0.25,0.61,0.67,0.72,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">risk factor for MS. Overt EBV-specific immune responses in MS </text>
   <text y="571.953" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.323,96.319,99.316,103.312,105.274,109.774,114.274,116.776,120.772,125.272,127.774,130.276,134.272,136.774,139.276,143.776,145.738,150.238,154.234,156.736,161.236,165.736,170.236,174.232,178.732,181.234,185.23,187.192,191.188,193.69,196.192,200.692,204.688,207.685,209.647,214.147,216.649,219.646,223.642,227.638,230.14,234.136,238.636,240.598,243.1,247.6,249.562,252.064,256.564,259.066,262.063,266.059,269.056,273.052,277.048,280.045,284.041,288.541,291.538,295.534,298.036" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.33,0.44,0.25,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.33,0.44,0.33,0.44,0.44,0.33,0.44,0.5,0.33,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients are potentially pathogenic either directed to intra-cerebral </text>
   <text y="582.951" x="62.362,67.861,73.864,80.2,82.45,84.952,89.452,92.449,96.445,100.441,102.943,105.445,109.945,114.445,116.695,121.195,124.192,126.442,130.438,133.435,137.935,141.436,144.937,147.934,150.931,154.927,158.923,162.919,165.421,167.923,172.423,176.419,178.669,182.665,187.165,189.667,194.167,198.163,202.663,205.165,207.667,212.167,216.163,220.663,224.164" svgx:width="0.61,0.67,0.72,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.33,0.5,0.39,0.39,0.33,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">EBV infection or cross-reactive autoantigens.</text>
   <text y="593.949" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="593.949" x="109.315,117.091,121.087,123.337,124.552,129.052,133.048,135.55,139.546,142.543,149.545,152.047,156.547,160.543,165.043,167.293,168.508,171.01,175.51,179.506,181.756,182.971,185.968,188.965,192.961,197.461,201.961,205.957,210.457,214.453,218.368,220.618,222.868,224.083,228.583,233.083,237.079,241.579,246.079,248.581,253.081,257.581,261.577,263.827,265.042,269.038,273.538,278.038,280.288,281.503,285.499,289.999,292.501,295.003" svgx:width="0.94,0.44,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We determined the frequency, phenotype and anti-</text>
   <text y="604.947" x="62.362,66.862,70.858,75.358,78.859,80.713,83.71,87.706,91.702,96.202,100.702,105.202,107.704,111.7,115.696,120.196,122.05,126.55,131.05,132.742,137.413,140.41,144.406,148.402,150.904,153.406,156.907,158.761,161.263,165.763,167.617,171.613,175.609,178.606,182.602,187.102,190.099,194.599,198.1,202.6,205.102,209.602,213.598,216.1,217.954,220.951,223.453,227.953,230.455,234.955,236.809,239.806,245.809,250.813,255.817,258.814,260.668,265.168,268.165,270.019,274.519,278.515,281.017,283.519,287.515,292.015,294.517,298.018" svgx:width="0.5,0.44,0.5,0.39,0.25,0.33,0.44,0.44,0.5,0.5,0.5,0.28,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.44,0.44,0.33,0.44,0.5,0.33,0.5,0.39,0.5,0.28,0.5,0.44,0.28,0.25,0.33,0.28,0.5,0.28,0.5,0.25,0.33,0.67,0.56,0.56,0.33,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gens recognized by T-cells in cerebrospinal fluid (CSF) of patients </text>
   <text y="615.945" x="62.362,68.86,71.362,73.864,78.364,80.353,84.349,86.851,89.353,93.853,96.355,100.351,104.347,106.849,109.351,113.851,115.84,118.342,121.843,126.343,128.845,132.841,135.343,139.339,143.839,145.828,149.329,153.829,158.329,162.829,165.826,170.326,177.328,181.324,183.313,186.31,192.313,195.31,200.314,203.311,205.561,207.55,211.546,215.047,217.549,221.545,226.045,228.547,231.049,234.55,239.05,243.046,247.546,249.535,257.536,262.54,264.529,268.525,273.025,277.525,279.514,284.014,286.516,291.016,295.012,298.009" svgx:width="0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.25,0.33,0.67,0.33,0.56,0.33,0.25,0.25,0.44,0.39,0.28,0.44,0.5,0.28,0.28,0.39,0.5,0.44,0.5,0.25,0.89,0.56,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with clinically isolated syndrome (CIS), established MS and other </text>
   <text y="626.943" x="62.362,66.862,70.858,75.358,78.355,82.855,85.357,89.857,94.357,96.859,100.855,104.851,107.353,109.603,114.103,116.605,120.106,124.102,128.098,131.599,135.595,137.845,140.842,147.34,153.838,160.336,163.333" svgx:width="0.5,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.33,0.72,0.72,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neurological disease (OND).</text>
   <text y="637.941" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="637.941" x="102.385,108.388,113.392,118.396,121.393,125.893,129.889,132.886,135.388,139.888,143.884,148.384,150.634,151.75,156.421,159.418,163.414,167.41,169.912,172.414,174.664,175.942,178.444,180.946,185.446,189.442,192.943,195.193,196.471,199.468,205.471,210.475,215.479,218.476,223.975,229.978,235.477,238.474,240.724,242.002,248.5,252.496,255.493,259.489,261.739,263.017,267.517,271.513,276.013,280.009,283.006,287.002,289.504,293.5,298.0" svgx:width="0.67,0.56,0.56,0.33,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.55,0.28,0.28,0.5,0.44,0.39,0.25,0.55,0.33,0.67,0.56,0.56,0.33,0.61,0.67,0.61,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CSF-derived T-cell lines (CSF-TCL) were generated </text>
   <text y="648.939" x="62.362,67.042,71.722,73.972,75.511,82.693,85.375,88.057,92.737,97.417,101.593,106.273,108.955,113.131,115.381,116.92,120.601,123.283,125.965,133.147,137.827,140.509,144.685,147.367,150.049,154.729,159.409,161.659,163.198,167.878,171.055,173.305,174.844,178.525,183.205,186.382,191.062,193.744,198.424,202.105,204.355,205.894,212.077,217.261,222.445,224.695,226.234,229.411,232.588,237.268,244.45,246.7,248.239,252.919,257.095,259.777,262.459,266.635,271.315,273.997,277.678,279.928,281.467,288.145,290.827,293.509,298.009" svgx:width="0.5,0.5,0.25,0.55,0.78,0.28,0.28,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.5,0.33,0.5,0.28,0.5,0.39,0.25,0.55,0.67,0.56,0.56,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">by mitogenic stimulation of surplus CSF from patients with </text>
   <text y="659.937" x="62.362,68.545,71.722,76.906,79.156,80.452,83.629,88.309,93.565,98.245,102.925,106.102,108.532,110.782,112.078,120.259,125.443,127.693,128.989,132.166,136.846,142.102,146.782,151.462,154.639,156.889,158.185,162.361,167.041,171.721,173.971,175.267,181.945,188.623,195.301,197.551,198.847,202.024,206.704,211.96,216.64,221.32,224.497,226.927,229.177,229.978,236.656,241.336,244.018,248.698,251.38,256.06,260.74,265.42,270.1,273.781,276.031,277.327,283.006,289.189,295.039" svgx:width="0.67,0.33,0.56,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.55,0.89,0.56,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.72,0.72,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.5,0.39,0.25,0.55,0.61,0.67,0.72,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CIS (n=17), MS (n=12) and OND (n=13). Autologous EBV-</text>
   <text y="670.935" x="62.362,64.864,67.861,71.857,76.357,79.858,82.855,87.355,90.352,97.354,101.35,105.85,108.235,114.238,117.235,121.231,125.227,127.729,130.231,133.732,136.117,139.114,143.11,147.61,150.112,154.612,160.615,166.114,172.117,177.616,180.613,182.998,189.496,193.492,196.489,200.485,202.87,207.37,210.871,214.867,219.367,221.752,225.748,229.249,231.634,235.63,240.13,242.632,245.134,249.634,253.63,258.13,260.515,265.015,268.012,272.008,275.509,279.505,284.005,286.507,289.009,293.509,298.009" svgx:width="0.28,0.33,0.44,0.5,0.39,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.44,0.5,0.28,0.5,0.67,0.61,0.67,0.61,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.39,0.44,0.5,0.25,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">transformed B-cells (autoBLCL) were used as antigen presenting </text>
   <text y="681.933" x="62.362,66.358,70.354,72.856,75.358,77.608,78.481,81.478,87.976,92.98,98.983,101.98,104.23,105.103,107.605,112.105,114.355,115.228,119.224,122.725,126.226,130.222,134.722,136.972,137.845,140.347,144.847,148.843,151.093,151.966,154.963,158.959,162.955,166.951,169.453,171.955,176.455,178.957,181.459,185.959,188.209,189.082,192.079,195.076,200.08,206.578,210.556,212.806,213.679,217.675,222.175,226.675,229.672,233.668,237.169,240.67,243.172,247.672,252.172,255.169,257.419,259.669,260.542,265.042,269.542,273.538,278.038,282.538,285.04,289.54,294.04,298.036" svgx:width="0.44,0.44,0.28,0.28,0.25,0.55,0.33,0.72,0.56,0.67,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.33,0.56,0.72,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cell (APC) to assay the reactivity (IFNγ expression), phenotype </text>
   <text y="692.931" x="62.362,65.359,71.362,77.86,82.36,84.862,90.865,97.363,101.863,104.86,107.11,108.109,112.105,116.605,121.105,123.355,124.354,128.35,130.852,135.352,139.852,143.848,146.35,148.852,151.354,155.854,158.104,159.103,162.1,167.599,173.602,178.885,185.383,189.883,192.133,193.132,197.632,201.133,205.129,209.629,213.625,216.622,218.872,219.871,224.371,227.368,229.618,230.617,236.62,241.624,246.628,249.625,255.124,261.127,266.293,268.543,269.542,272.044,276.544,283.042,287.038,290.035,294.535,298.036" svgx:width="0.33,0.67,0.72,0.5,0.28,0.67,0.72,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.28,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.55,0.33,0.61,0.67,0.67,0.72,0.5,0.25,0.55,0.5,0.39,0.44,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.56,0.56,0.33,0.61,0.67,0.61,0.25,0.55,0.28,0.5,0.72,0.44,0.33,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(CD4/CD8) and clonality (TCRVß usage) of CSF-TCL towards </text>
   <text y="703.929" x="62.362,67.861,73.864,79.201,81.451,83.701,84.61,90.109,94.609,98.605,100.855,101.926,106.426,110.422,112.924,115.426,119.422,123.922,126.424,129.925,132.256,134.506,135.577,141.076,147.079,152.749,155.746,158.743,162.739,166.24,168.742,171.739,174.241,178.237,180.739,183.241,187.741,192.241,194.491,195.562,202.06,207.559,214.057,217.054,220.051,222.301,223.372,227.368,229.87,232.372,236.368,238.87,242.866,245.116,246.187,252.685,256.681,260.182,262.432,263.503,266.005,270.505,274.501,279.001,281.503,284.005,287.002,289.504,293.5,298.0" svgx:width="0.61,0.67,0.72,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.33,0.25,0.55,0.61,0.67,0.72,0.33,0.33,0.44,0.39,0.28,0.33,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.61,0.72,0.33,0.33,0.25,0.55,0.44,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">EBV. The patients’ EBV-restricting HLA-I allele was identified </text>
   <text y="714.927" x="62.362,66.862,70.363,72.865,77.365,81.865,84.115,86.41,90.91,94.906,97.903,100.405,102.907,106.903,109.405,111.907,116.407,118.657,120.952,127.45,132.949,139.447,142.444,149.446,153.442,155.944,159.94,164.44,168.436,172.936,175.186,177.472,181.468,183.97,186.472,190.972,195.472,199.468,203.968,206.47,210.466,212.716,215.011,221.014,226.513,232.516,238.015,240.265,242.515,244.81,249.814,252.316,256.816,260.812,263.314,265.816,269.731,271.981,274.231,276.526,282.529,287.029,290.53,293.527,298.027" svgx:width="0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.72,0.61,0.72,0.33,0.78,0.44,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.67,0.61,0.67,0.61,0.25,0.25,0.55,0.56,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.67,0.5,0.39,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">using partially HLA-matched allogenic BLCL. Finally, Cos-7 </text>
   <text y="725.925" x="62.362,66.358,70.354,72.856,75.358,78.859,81.109,83.593,90.091,94.087,97.084,101.08,103.33,105.814,109.81,114.31,117.307,119.809,122.806,126.802,131.302,134.803,137.8,141.796,145.792,148.294,152.29,156.79,159.04,161.524,168.022,170.524,173.026,177.526,179.776,182.26,184.762,189.262,193.258,195.508,197.992,202.492,206.488,208.99,211.492,215.488,219.988,222.49,224.992,228.493,230.743,233.227,238.726,244.729,251.065,253.315,255.799,261.802,268.3,272.8,275.05,277.372,282.043,285.04,289.036,293.032,295.534,298.036" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.33,0.28,0.33,0.44,0.5,0.39,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.39,0.25,0.55,0.61,0.67,0.72,0.25,0.55,0.67,0.72,0.5,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells were co-transfected with the patient’s EBV CD8 T-cell </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M444.540 425.300 L492.280 425.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,313.013,317.009,320.51,325.01,329.51,334.01,337.511,341.507,343.757,345.107,348.104,352.1,355.601,358.103,361.1,363.602,367.598,370.1,372.602,377.102,381.602,383.852,385.202,391.7,397.199,403.697,406.694,409.691,411.941,413.291,417.287,419.789,422.291,426.287,428.789,432.785,435.035,436.385,440.381,444.881,451.883,456.383,458.885,463.385,467.381,471.881,474.131,475.481,481.979,484.481,486.983,491.483,493.733,495.083,498.08,502.58,505.577,507.827,509.177,511.679,516.179,520.679,523.181,527.681,530.183,534.683,539.183,543.179,545.681" svgx:width="0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.55,0.33,0.44,0.39,0.28,0.33,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.61,0.72,0.33,0.33,0.25,0.55,0.44,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">response restricting HLA-I allele combined with (1) individual </text>
   <text y="88.101" x="310.016,314.516,317.018,321.014,324.515,331.517,334.019,338.519,342.02,344.819,348.815,353.315,357.311,361.811,366.311,368.813,373.313,377.813,380.612,385.112,389.612,392.42,396.92,399.917,402.716,405.218,409.718,413.714,416.513,419.015,423.515,426.017,430.013,432.515,435.314,439.814,442.811,445.619,450.119,454.619,457.418,460.415,464.915,469.415,476.912,479.909,482.708,487.208,491.708,496.208,502.706,507.206,510.014,515.513,521.516,527.852,530.66,535.16,538.157,542.657" svgx:width="0.5,0.28,0.44,0.39,0.78,0.28,0.5,0.39,0.25,0.44,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.5,0.5,0.5,0.72,0.5,0.25,0.61,0.67,0.72,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">plasmids encoding 59 of the total of 86 (69%) known EBV pro-</text>
   <text y="99.099" x="310.016,312.518,316.514,319.016,323.516,327.017,329.186,333.686,336.683,338.852,341.849,346.349,349.346,351.515,359.516,364.52,367.517,371.513,375.014,378.515,383.015,387.011,389.513,393.509,396.011,400.007,404.507,406.676,411.176,415.676,422.678,426.674,431.174,433.343,437.843,440.345,442.847,447.347,451.847,456.347,460.343,464.843,469.343,472.34,476.84,480.836,485.336,487.838,491.834,494.831,497.0,499.997,507.998,514.496,520.994,523.244,525.413,533.414,539.417,543.422,545.672" svgx:width="0.28,0.44,0.28,0.5,0.39,0.25,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.89,0.56,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.78,0.44,0.5,0.25,0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.33,0.25,0.33,0.89,0.72,0.72,0.25,0.25,0.89,0.67,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">teins or (2) MS-associated human oligodendrocyte- (MAG, MBP, </text>
   <text y="110.097" x="310.016,318.017,324.515,331.013,332.894,336.89,341.39,345.89,347.771,352.775,358.274,363.278,367.778,370.775,373.025,374.906,379.406,381.908,384.41,388.406,391.403,393.284,396.281,402.284,407.792,413.291,419.789,425.792,428.042,429.923,436.421,439.418,445.421,449.921,452.171,456.671,458.552,462.548,467.048,471.548,473.429,478.433,482.933,487.433,491.933,497.936,500.933,502.814,506.81,511.31,515.81,517.691,522.191,526.187,530.687,533.684,538.184,542.684" svgx:width="0.89,0.72,0.72,0.25,0.44,0.5,0.5,0.25,0.56,0.61,0.56,0.5,0.33,0.25,0.25,0.5,0.28,0.28,0.44,0.33,0.25,0.33,0.67,0.67,0.72,0.72,0.67,0.25,0.25,0.72,0.33,0.67,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.56,0.5,0.5,0.5,0.67,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MOG and PLP1), glia- (CRYAB, KIR4.1 and S100B) and neuron-</text>
   <text y="121.095" x="310.016,313.517,318.017,322.013,326.009,328.511,331.508,334.01,338.006,340.715,345.215,348.212,352.712,355.214,359.21,361.712,366.212,369.713,372.422,375.419,381.422,387.92,393.419,399.917,404.417,407.126,411.122,415.622,420.122,422.831,429.329,434.333,438.833,443.333,447.833,450.83,453.539,457.535,462.035,466.535,469.244,472.745,477.245,481.745,485.246,489.242,493.742,498.242,502.238,506.738,509.24,511.742,516.242,518.951,523.451,526.952,530.948,535.448,538.157,542.153,545.654" svgx:width="0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.39,0.25,0.33,0.67,0.72,0.61,0.72,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.56,0.5,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.5,0.39,0.44,0.5,0.25,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">specific proteins (CNTN2 and NF155) and subsequently used as </text>
   <text y="132.093" x="310.016,316.514,321.518,327.521,329.771,332.273,336.773,339.023,342.02,346.52,351.02,355.016,357.518,360.02,364.52,369.02,373.016,375.518,377.606,382.277,385.274,389.27,393.266,395.768,398.27,400.52,404.516,408.017,411.518,415.514,420.014,423.515" svgx:width="0.72,0.56,0.67,0.25,0.28,0.5,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.44,0.39,0.39,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">APC in functional T-cell assays.</text>
   <text y="143.091" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="143.091" x="344.477,349.481,352.478,356.474,360.974,365.474,369.47,373.97,377.966,380.468,384.464,387.965,390.215,391.43,395.93,398.927,401.177,402.392,406.388,410.888,413.39,417.89,423.893,429.392,435.395,440.561,442.811,444.026,447.023,451.019,455.015,459.011,461.513,464.015,468.515,472.511,474.761,475.976,481.979,486.983,491.987,494.984,500.483,506.486,511.985,514.235,516.485,517.7,522.2,526.196,529.193,531.695,534.197,538.193,542.693" svgx:width="0.56,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.5,0.67,0.61,0.67,0.61,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.67,0.56,0.56,0.33,0.61,0.67,0.61,0.25,0.25,0.55,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Frequencies of autoBLCL reactive CSF-TCL, particu-</text>
   <text y="154.089" x="310.016,312.518,316.514,319.511,322.013,326.513,328.763,330.113,336.116,342.614,347.114,349.364,350.552,355.223,358.22,362.216,366.212,368.714,371.216,374.717,376.967,379.217,380.567,387.065,391.061,394.058,398.054,400.304,401.654,405.155,407.657,412.157,416.657,419.159,422.156,424.658,428.654,432.65,437.15,439.652,442.154,446.654,448.904,450.254,452.756,457.256,461.252,464.249,468.245,472.241,475.742,479.738,484.238,486.488,487.838,490.34,494.84,497.09,498.44,506.441,511.445,513.6949999999999,515.045,519.041,523.541,528.041,530.291,531.641,537.644,540.641,545.645" svgx:width="0.28,0.44,0.33,0.28,0.5,0.25,0.55,0.67,0.72,0.5,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">larly CD8 T-cells, were significantly increased in MS and CIS </text>
   <text y="165.087" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,340.265,341.048,345.044,349.544,356.546,361.046,365.042,368.039,372.035,376.535,378.785,379.568,382.07,386.57,388.82,389.603,396.101,402.599,409.097,411.347,413.597,414.38,420.878,424.874,427.376,431.372,433.874,436.376,440.372,444.872,447.122,447.905,451.901,456.401,460.397,462.899,467.399,470.9,474.896,478.397,480.647,481.43,485.93,488.927,491.177,491.96,497.963,502.967,507.971,510.968,516.467,522.47,527.636,529.886,530.669,535.169,538.166,540.416,541.199,545.699" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.72,0.72,0.25,0.25,0.55,0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.56,0.56,0.33,0.61,0.67,0.61,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients compared to OND. Detailed analyses of CSF-TCL of 5 </text>
   <text y="176.085" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,340.265,344.279,350.777,353.279,355.781,360.281,362.531,366.545,371.045,373.547,378.047,382.547,384.797,388.811,391.808,396.884,401.384,405.884,413.381,416.378,418.628,422.642,426.638,431.138,433.64,438.14,444.143,449.642,455.645,461.144,464.141,467.642,472.142,476.138,480.134,482.636,485.633,488.135,492.131,494.381,498.395,504.398,510.896,515.396,517.646,521.498,526.169,529.166,533.162,537.158,539.66,542.162,545.663" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.5,0.5,0.83,0.33,0.25,0.55,0.44,0.5,0.28,0.5,0.67,0.61,0.67,0.61,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.67,0.72,0.5,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with high (&gt;10%) autoBLCL-specific CD8 T-cells </text>
   <text y="187.083" x="310.016,314.516,318.512,325.514,330.014,334.514,338.015,340.517,343.514,347.51,350.012,354.008" svgx:width="0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">demonstrated</text>
   <text y="204.084" x="324.02,327.017,331.517,334.514,336.764,342.02,346.016,350.516,352.766,357.266,359.768,362.27,366.77,371.27,375.266,377.768,382.268,386.768,390.764,393.266,395.516,401.519,408.017,412.517,414.605,419.276,422.273,426.269,430.265,432.767,435.269,437.519,440.516,444.512,448.013,452.513,457.013,461.513,465.014,469.01,472.511,474.761,478.757,483.257" svgx:width="0.33,0.5,0.33,0.25,0.55,0.44,0.5,0.25,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.67,0.72,0.5,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(1) an oligoclonal CD8 T-cell responses and</text>
   <text y="215.082" x="324.02,327.017,331.517,334.514,336.764,342.02,345.521,349.517,352.019,356.015,360.011,362.513,365.015,369.515,373.511,376.355,382.358,388.856,393.356,396.038,400.709,403.706,407.702,411.698,414.2,416.702,419.546,422.543,426.539,430.535,434.531,437.033,439.535,444.035,446.537,449.039,453.539,456.383,458.885,463.385,466.229,468.731,473.231,475.733,478.235,482.231,485.075,488.072,494.075,498.071,504.074,509.078,513.578,516.422,522.425,528.428,533.927,538.931,543.431,545.681" svgx:width="0.33,0.5,0.33,0.25,0.55,0.39,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.67,0.72,0.5,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.28,0.44,0.25,0.33,0.67,0.44,0.67,0.56,0.5,0.25,0.67,0.67,0.61,0.56,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(2) selective CD8 T-cell reactivity to lytic (BaRF1 BRLF1, </text>
   <text y="226.08" x="342.02,348.023,354.026,360.029,365.033,369.533,371.783,373.727,379.73,385.733,391.736,396.74,401.24,403.184,407.18,411.68,416.18,418.124,424.127,430.625,436.124,441.128,445.628,448.625,450.875,452.819,457.319,461.819,464.321,466.265,470.765,475.265,477.767,479.711,482.213,486.209,488.711,492.707,497.207,501.203,505.703,508.7,512.696,516.197,519.698,524.198,528.194,530.696,534.692,537.194,541.19,545.69" svgx:width="0.67,0.67,0.67,0.56,0.5,0.25,0.25,0.67,0.67,0.67,0.56,0.5,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.61,0.56,0.5,0.33,0.25,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.28,0.25,0.28,0.44,0.28,0.44,0.5,0.44,0.5,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">BCRF1, BBRF3 and BXLF1), but not latency-associated </text>
   <text y="237.078" x="342.02,347.519,353.522,359.858,362.108,366.608,369.605,374.105,376.607,380.603,383.105,387.605,391.106" svgx:width="0.61,0.67,0.72,0.25,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">EBV proteins.</text>
   <text y="254.079" x="310.016,315.02,317.522,322.022,326.018,328.52,331.022,334.937,337.187,339.437,341.138,345.638,349.634,352.136,354.638,359.138,363.134,366.131,368.381,370.082,374.582,377.084,381.584,386.084,388.334,390.035,394.031,398.531,401.033,405.533,411.536,417.035,423.038,428.204,430.454,432.155,438.158,444.656,449.156,451.406,452.945,457.616,460.613,464.609,468.605,471.107,473.609,475.859,477.56,480.557,484.553,488.549,492.545,495.047,497.549,502.049,506.045,508.295,509.996,515.999,521.003,526.007,529.004,534.503,540.506,545.672" svgx:width="0.56,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.67,0.61,0.67,0.61,0.25,0.55,0.67,0.72,0.5,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.67,0.56,0.56,0.33,0.61,0.67,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Finally, neither high autoBLCL CD8 T-cell reactive CSF-TCL </text>
   <text y="265.077" x="310.016,313.013,317.009,320.51,325.01,329.51,334.01,338.51,342.506,347.006,349.256,351.758,356.258,362.756,366.752,369.749,374.249,377.75,380.0,382.502,387.002,390.998,393.248,397.748,399.998,407.999,413.003,416.0,419.996,423.497,426.998,431.498,435.494,437.996,441.992,444.494,448.49,452.99,455.24,459.236,463.736,466.238,470.738,474.734,479.234,481.736,484.238,488.738,492.734,497.234,500.735,502.985,506.981,510.482,513.983,517.979,522.479,526.475,530.975" svgx:width="0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.72,0.44,0.33,0.5,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.25,0.89,0.56,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.39,0.25,0.44,0.39,0.39,0.44,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">responded towards the 9 MS-associated autoantigens assayed.</text>
   <text y="276.075" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="276.075" x="364.655,371.153,375.653,378.155,382.655,388.658,394.157,400.16,405.659,408.656,412.157,416.657,420.653,424.649,427.151,430.148,432.65,436.646,438.896,441.776,447.779,454.277,458.777,461.027,463.907,467.903,472.403,476.903,479.153,482.033,486.533,490.529,493.526,496.028,498.53,502.526,507.026,509.528,513.524,516.521,519.023,523.523,525.773,528.653,534.656,541.154,545.654" svgx:width="0.72,0.5,0.28,0.5,0.67,0.61,0.67,0.61,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.67,0.72,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.28,0.44,0.33,0.28,0.5,0.25,0.55,0.67,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">AutoBLCL-specific CD4 and particularly CD8 </text>
   <text y="287.073" x="310.016,314.687,317.684,321.68,325.676,328.178,330.68,333.101,336.098,340.094,343.595,348.095,352.595,357.095,360.596,364.592,368.093,370.514,377.012,381.008,384.005,388.001,390.422,393.923,396.425,400.925,405.425,407.927,410.924,413.426,417.422,421.418,425.918,428.42,430.922,435.422,437.843,440.345,444.845,448.841,451.838,455.834,459.83,463.331,467.327,471.827,474.248,476.75,481.25,483.671,489.674,494.678,499.682,502.679,508.178,514.181,519.347,521.768,526.268,529.265,531.686,537.689,540.686,545.69" svgx:width="0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.67,0.56,0.56,0.33,0.61,0.67,0.61,0.25,0.5,0.33,0.25,0.67,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T-cell responses were significantly increased in CSF-TCL of CIS </text>
   <text y="298.071" x="310.016,314.012,318.512,323.012,324.857,332.858,337.862,339.707,344.207,348.203,350.705,353.207,357.203,361.703,364.205,367.706,369.551,373.547,378.047,385.049,389.549,393.545,396.542,400.538,405.038,406.883,409.385,413.885,415.73,422.228,428.726,435.224,437.474,439.319,442.316,446.816,449.318,452.315,456.311,459.308,465.311,470.315,475.319,477.164,481.16,485.66,488.162,492.662,498.665,504.164,510.167,515.333,517.178,520.175,524.171,528.167,532.163,534.665,537.167,541.667,545.663" svgx:width="0.44,0.5,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.72,0.72,0.25,0.25,0.33,0.5,0.28,0.33,0.44,0.33,0.67,0.56,0.56,0.25,0.44,0.5,0.28,0.5,0.67,0.61,0.67,0.61,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and MS patients compared to OND. Intra-CSF autoBLCL reactive </text>
   <text y="309.069" x="310.016,316.019,322.517,327.017,329.834,334.505,337.502,341.498,345.494,347.996,350.498,353.999,356.249,356.978,363.476,367.472,370.469,374.465,376.715,377.444,380.945,384.941,387.443,391.439,395.435,397.937,400.439,404.939,408.935,411.437,415.937,418.187,418.916,423.416,425.918,428.915,432.911,436.907,439.409,443.405,447.905,450.155,450.884,453.386,457.886,460.136,460.865,463.367,467.867,470.369,472.871,476.867,479.117,479.846,485.345,491.348,497.684,499.934,500.663,505.163,508.16,512.66,515.162,519.158,521.66,526.16,529.661,531.911,532.64,536.636,541.136,545.636" svgx:width="0.67,0.72,0.5,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.28,0.28,0.44,0.25,0.55,0.61,0.67,0.72,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD8 T-cells were selectively directed to lytic EBV proteins and </text>
   <text y="320.067" x="310.016,314.516,317.018,321.518,324.173,328.673,333.173,335.675,338.33,342.326,345.323,349.823,353.324,356.825,359.822,362.819,366.815,370.811,374.807,377.309,379.964,386.462,388.964,391.466,395.966,398.621,406.622,411.626,414.623,418.619,422.12,425.621,430.121,434.117,436.619,440.615,443.117,447.113,451.613,454.268,458.768,463.268,470.27,474.266,478.766,481.421,485.417,489.917,492.419,496.919,500.915,505.415,507.917,510.419,514.919,518.915,523.415,526.916,529.166,531.659,537.158,541.658,545.654" svgx:width="0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.44,0.33,0.5,0.39,0.39,0.33,0.33,0.44,0.44,0.44,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.33,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.78,0.44,0.5,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.39,0.25,0.25,0.61,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">did not cross-react with MS-associated human autoantigens. The </text>
   <text y="331.065" x="310.016,314.012,316.514,320.51,325.01,329.006,331.508,335.504,340.004,342.434,346.43,350.93,355.43,357.86,361.361,365.357,367.859,371.855,375.851,378.353,380.855,385.355,389.351,391.781,394.778,398.774,402.77,407.27,411.77,416.27,418.772,421.274,423.776,428.276,432.776,435.206,439.706,442.703,445.133,447.635,452.135,454.637,457.139,461.135,463.565,469.064,475.067,481.403,483.833,488.333,491.33,495.83,498.332,502.328,504.83,509.33,512.831,515.261,519.761,524.261,526.691,532.694,537.698,542.702" svgx:width="0.44,0.28,0.44,0.5,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.44,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.28,0.44,0.25,0.61,0.67,0.72,0.25,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.39,0.25,0.5,0.5,0.25,0.67,0.56,0.56,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">elevated and selective recognition of lytic EBV proteins by CSF-</text>
   <text y="342.063" x="310.016,314.516,318.512,321.509,324.011,328.511,332.507,337.007,338.843,344.846,351.344,355.844,357.518,362.189,365.186,369.182,373.178,375.68,378.182,381.683,383.519,386.021,393.023,397.523,400.025,402.527,406.523,410.519,413.021,417.017,418.853,422.849,424.685,427.187,431.687,435.683,439.679,442.181,444.017,449.516,455.519,461.855,463.691,466.193,470.693,473.69,477.686,481.682,484.184,486.686,491.186,495.686,497.522,500.024,504.524,506.36,510.356,512.192,515.693,520.193,524.693,529.193,532.19,536.69,541.19,545.69" svgx:width="0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.67,0.72,0.5,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.25,0.44,0.25,0.28,0.5,0.44,0.44,0.28,0.25,0.61,0.67,0.72,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">derived CD8 T-cells implicate a local EBV infection in a subgroup </text>
   <text y="353.061" x="310.016,314.516,317.513,319.763,325.766,328.763,333.767,336.017,340.013,344.513,349.013,351.263,359.264,364.268,366.518,371.018,375.014,377.516,380.018,384.014,388.514,391.016,394.517" svgx:width="0.5,0.33,0.25,0.67,0.33,0.56,0.25,0.44,0.5,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of CIS and MS patients.</text>
   <text y="380.061" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P565</text>
   <text y="391.059" x="310.016,318.512,321.014,325.01,329.006,333.506,340.004,346.502,353.0,355.25,362.747,365.249,371.747,374.744,379.244,383.744,385.994,388.496,391.997,394.247,396.749,401.753,406.757,411.761,415.757,419.753,424.757,427.007,432.011,436.511,438.761,441.263,446.267,449.264,453.26,457.256,460.253,464.249,468.245,472.745,477.749,480.746,485.75,489.746,492.743,497.243,499.493,503.993,508.997,514.001" svgx:width="0.94,0.28,0.44,0.44,0.5,0.72,0.72,0.72,0.25,0.83,0.28,0.72,0.33,0.5,0.5,0.25,0.28,0.39,0.25,0.28,0.56,0.56,0.56,0.44,0.44,0.56,0.25,0.56,0.5,0.25,0.28,0.56,0.33,0.44,0.44,0.33,0.44,0.44,0.5,0.56,0.33,0.56,0.44,0.33,0.5,0.25,0.5,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">MicroRNA miR-21 is induced by interferon-beta and </text>
   <text y="402.057" x="310.016,312.518,317.522,322.526,325.028,330.032,332.534,335.531,339.032,341.282,344.783,350.786,353.783,358.283,362.783,365.033,369.029,373.529,378.533,382.529,386.525,390.026,393.527,396.029,400.529,405.533,408.53,410.78,415.28,417.53,422.534,427.034,431.534,435.53,438.032,440.282,442.784,450.281,457.778,462.782,467.786,472.286,479.783,484.283,489.287,494.291,496.793,501.293,504.29,508.79,512.786,517.286" svgx:width="0.28,0.56,0.56,0.28,0.56,0.28,0.33,0.39,0.25,0.39,0.67,0.33,0.5,0.5,0.25,0.44,0.5,0.56,0.44,0.44,0.39,0.39,0.28,0.5,0.56,0.33,0.25,0.5,0.25,0.56,0.5,0.5,0.44,0.28,0.25,0.28,0.83,0.83,0.56,0.56,0.5,0.83,0.5,0.56,0.56,0.28,0.5,0.33,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">inhibits IL-12 expression: a novel immunomodulatory </text>
   <text y="413.055" x="310.016,317.513,321.509,325.505,330.509,335.009,340.013,342.515,346.016,353.513,355.763,358.265,363.269,365.519,373.016,378.02,380.522,383.519,386.021,391.025,393.527,397.523,399.773,403.274,407.27,409.772,413.768,417.764,422.264,425.765,428.267" svgx:width="0.83,0.44,0.44,0.56,0.5,0.56,0.28,0.39,0.83,0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">mechanism in multiple sclerosis</text>
   <text y="424.053" x="310.016,315.515,321.014,323.264,329.762,334.262,338.762" svgx:width="0.61,0.61,0.25,0.72,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LL Aung</text>
   <text y="421.583" x="343.262" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="424.103" x="346.186,348.436,350.686,357.184,359.434,365.437,369.937,372.439,375.94" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.28,0.39,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, V Bhise</text>
   <text y="421.583" x="379.936" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="424.103" x="382.861,385.111,387.361,392.365,394.615,401.113,405.613,408.115,412.615,415.612,419.113,423.109,425.611,430.111,434.611" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.28,0.5,0.33,0.39,0.44,0.28,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Dhib-Jalbut</text>
   <text y="421.583" x="437.113" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="424.103" x="440.038,442.288,444.538,451.036,456.535,458.785,464.788,468.784,471.286,475.282,478.783,483.283,487.783" svgx:width="0.25,0.25,0.72,0.61,0.25,0.67,0.44,0.28,0.44,0.39,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, KE Balashov</text>
   <text y="421.583" x="492.282" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="432.581" x="310.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="435.103" x="312.941,318.44,322.94,325.442,329.942,333.938,337.439,340.94,343.937,349.436,353.936,358.436,362.432,365.933,368.435,370.685,378.182,382.682,387.182,391.682,393.932,397.928,402.428,406.928,411.428,414.929,419.429,423.929,426.179,433.676,437.672,442.172,444.674,448.67,453.17,455.672,457.922,462.422,466.418,470.918,475.418,479.918,482.42,484.67,486.92,492.923,496.919,501.419,504.92,509.42,511.922,516.422,520.922,524.918,527.168,529.418,535.421,539.417,545.42" svgx:width="0.61,0.5,0.28,0.5,0.44,0.39,0.39,0.33,0.61,0.5,0.5,0.44,0.39,0.28,0.25,0.83,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.39,0.5,0.5,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.67,0.44,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Rutgers-Robert Wood Johnson Medical School, Neurology, New </text>
   <text y="446.101" x="310.016,315.515,319.016,323.516,328.016,331.517,337.52,340.022,344.018,348.014,350.264,352.514,358.517,362.513,364.763,367.013,373.511,378.011,380.513,383.015,387.011,391.511,393.761,398.261,400.763,405.263,407.765,411.761" svgx:width="0.61,0.39,0.5,0.5,0.39,0.67,0.28,0.44,0.44,0.25,0.25,0.67,0.44,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Brunswick, NJ, United States</text>
   <text y="473.101" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="473.101" x="362.684,370.685,375.185,379.685,384.185,388.181,392.681,395.183,399.179,402.68,404.993,408.989,411.986,415.982,418.295,422.291,424.613,431.615,435.611,438.113,442.613,445.61,447.923,451.424,455.924,460.424,463.421,467.417,471.413,473.726,478.226,481.223,483.545,486.542,492.041,495.038,499.538,504.038,506.351,512.849,517.349,519.851,523.847,528.347,530.669,535.169,538.166,542.666" svgx:width="0.89,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.44,0.33,0.44,0.25,0.44,0.25,0.78,0.44,0.28,0.5,0.33,0.25,0.39,0.5,0.5,0.33,0.44,0.44,0.25,0.5,0.33,0.25,0.33,0.61,0.33,0.5,0.5,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Monocytes are a major source of IL-12 which pro-</text>
   <text y="484.099" x="310.016,317.018,321.518,324.02,328.016,331.517,333.767,335.36,339.86,343.856,348.356,352.352,355.349,359.345,361.847,364.349,368.849,373.349,375.599,377.192,381.692,384.689,386.939,388.37,393.869,398.369,402.869,405.119,406.712,410.708,414.704,417.206,419.708,423.209,425.459,427.052,431.048,435.548,440.048,442.298,443.891,447.392,451.388,455.384,458.381,462.377,464.879,467.381,471.881,476.381,478.631,480.224,484.724,487.721,489.971,491.564,494.561,499.565,506.063,509.06,513.56,517.556,524.558,531.56,535.556,537.806,540.056,541.649,545.645" svgx:width="0.78,0.5,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.56,0.72,0.33,0.5,0.44,0.78,0.78,0.44,0.25,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">motes generation of Th1 cells and secretion of IFN-gamma, a </text>
   <text y="495.097" x="310.016,314.012,318.512,321.014,325.514,330.014,332.516,337.016,341.012,343.505,346.007,350.507,354.503,357.005,359.498,362.0,364.997,367.499,371.999,376.499,380.495,383.492,386.993,389.486,397.487,401.987,404.489,406.991,409.493,413.993,416.495,420.491,422.984,427.988,431.984,434.486,438.482,441.479,445.979,449.48,451.982,455.483,457.976,460.973,468.974,473.978,476.975,479.468,482.465,486.461,488.963,492.959,497.459,500.96,504.956,508.457,510.707,513.2,516.197,521.201,527.699,530.696,535.196,539.192,541.694,545.69" svgx:width="0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.33,0.28,0.5,0.5,0.44,0.33,0.39,0.25,0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.56,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.33,0.56,0.72,0.33,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytokine that triggers Multiple Sclerosis (MS) relapses. IFN-beta </text>
   <text y="506.095" x="310.016,312.518,315.515,319.511,323.507,326.009,333.011,337.007,341.507,344.009,346.259,347.789,350.291,354.791,359.291,361.793,366.293,368.795,371.297,374.798,377.048,378.578,381.575,387.074,390.071,394.571,399.071,401.321,402.851,407.351,410.348,414.848,419.348,423.848,427.844,430.346,432.848,437.348,441.848,444.098,445.628,450.128,454.628,456.878,458.408,462.404,466.904,469.406,471.908,476.408,480.404,484.904,487.901,492.401,495.398,499.394,502.895,506.891,511.391,513.893,516.395,520.895,525.395,527.645,529.175,533.171,537.167,539.669,542.171,545.672" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.39,0.25,0.55,0.33,0.61,0.33,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.33,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment inhibits IL-12 production by antigen-presenting cells </text>
   <text y="517.093" x="310.016,314.012,318.512,323.012,325.262,326.027,330.527,334.523,338.519,341.516,345.512,349.508,353.009,357.005,360.506,362.756,363.521,366.023,370.523,374.519,376.769,377.534,380.531,383.528,387.524,392.024,396.524,400.52,405.02,409.016,413.516,415.766,416.531,421.031,424.028,426.278,427.043,435.044,440.048,442.298,443.063,446.06,450.056,452.558,456.554,461.054,464.555,468.551,472.052,474.302,477.155,482.654,487.154,491.15,493.4,494.165,501.167,505.163,509.159,513.659,517.655,522.155,524.657,528.158,535.16,537.41,538.175,542.675,545.672" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and decreases the frequency of MS relapses. The mechanism of </text>
   <text y="528.091" x="310.016,313.013,318.512,321.509,326.009,330.509,332.759,335.261,339.761,344.261,346.763,351.263,353.765,356.267,358.769,363.269,367.769,370.019,374.519,379.019,381.269,384.266,389.27,395.768,398.765,403.265,407.261,409.763,413.759,416.009,418.511,422.012,424.262,428.762,433.262,435.764,438.014,442.01,446.51,453.512,458.012,460.514,464.51,467.012,471.008,473.51,478.01,480.26,484.76,489.26,493.76,497.756,500.753,504.254,506.756,511.256,515.756,520.256" svgx:width="0.33,0.61,0.33,0.5,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.33,0.56,0.72,0.33,0.5,0.44,0.28,0.44,0.25,0.28,0.39,0.25,0.5,0.5,0.28,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.28,0.5,0.25,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IL-12 inhibition by IFN-beta is not completely understood.</text>
   <text y="539.089" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="539.089" x="355.394,360.263,364.763,366.653,370.649,373.151,377.651,381.647,384.149,388.649,392.645,395.147,399.143,401.033,407.531,412.031,416.027,418.529,423.029,427.025,430.022,431.912,438.914,441.416,445.412,448.409,452.909,458.912,465.41,471.908,475.409,477.299,480.296,487.298,489.8,495.803,502.301,508.799,512.3,515.297,517.187,521.183,525.683,530.183,532.685,535.682,538.184,542.684" svgx:width="0.61,0.5,0.25,0.44,0.28,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.78,0.28,0.44,0.33,0.5,0.67,0.72,0.72,0.39,0.25,0.33,0.78,0.28,0.67,0.72,0.72,0.39,0.33,0.25,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To elucidate whether microRNAs (miRNAs) contrib-</text>
   <text y="550.087" x="310.016,314.516,317.018,321.014,323.264,324.308,326.81,331.31,333.56,334.604,337.106,341.606,345.602,347.852,348.896,351.398,358.4,365.402,369.902,374.402,378.902,385.904,390.404,394.904,399.404,401.906,405.902,408.404,412.904,415.901,420.401,422.651,423.695,427.691,430.526,433.523,437.519,441.515,444.017,446.267,447.311,451.811,454.808,457.058,458.102,460.604,465.104,467.606,471.602,474.599,477.596,481.592,484.589,489.089,493.589,495.839,496.883,499.88,502.877,507.881,514.379,517.376,520.373,524.873,528.869,531.371,535.367,537.617,538.661,541.163,545.663" svgx:width="0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.25,0.55,0.33,0.33,0.56,0.72,0.33,0.33,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ute to the immunomodulatory effect of interferon (IFN)-beta in </text>
   <text y="561.085" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,340.265,346.763,349.265,351.767,356.267,358.517,366.518,371.522" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with MS.</text>
   <text y="572.083" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="572.083" x="350.003,358.004,362.504,367.004,371.504,375.5,380.0,382.502,386.498,389.999,392.249,393.491,399.989,403.985,406.982,410.978,413.228,414.47,417.971,421.967,426.467,430.463,433.46,437.456,439.958,443.954,448.454,450.704,451.946,454.943,457.94,462.44,469.442,471.692,472.934,477.434,479.684,480.926,485.426,489.422,493.418,495.92,498.422,502.922,507.422,509.672,510.914,515.414,519.914,524.414,528.914,531.911,535.412,537.662,539.912,541.154,545.654" svgx:width="0.89,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.39,0.25,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Monocytes were separated from 8 healthy donors, 8 </text>
   <text y="583.081" x="310.016,314.516,319.016,321.518,324.515,328.511,332.507,335.009,339.005,343.505,345.8,350.3,354.296,356.798,359.3,363.296,367.796,370.298,373.799,376.094,382.592,385.094,387.596,392.096,394.391,397.388,401.384,403.886,407.882,412.382,415.883,418.385,422.885,427.385,429.68,432.677,437.177,440.174,447.176,450.677,452.972,457.472,460.469,462.764,470.765,475.769,478.019,480.314,484.31,488.81,493.31,495.605,500.105,502.4,505.397,510.401,516.899,519.896,524.396,528.392,530.894,534.89,537.185,541.685,545.681" svgx:width="0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.33,0.5,0.33,0.78,0.39,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.33,0.56,0.72,0.33,0.5,0.44,0.28,0.44,0.25,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">untreated patients with relapsing forms of MS, and 8 IFN-beta 1a </text>
   <text y="594.079" x="310.016,313.013,317.513,322.013,329.015,333.011,337.511,339.761,340.877,343.874,351.875,354.125,355.241,361.739,365.735,369.731,374.231,376.733,381.233,384.23,386.48,387.596,390.098,393.095,397.091,401.087,403.589,407.585,412.085,414.335,415.451,423.452,428.456,430.706,431.822,436.322,440.318,442.82,445.322,449.318,453.818,456.32,459.821,462.071,464.321,465.437,472.439,474.941,480.944,487.442,493.445,495.695,496.811,500.807,505.307,509.807,512.804,516.8,520.301,523.802,526.304,530.804,535.304,537.554,538.67,541.172,545.672" svgx:width="0.33,0.5,0.5,0.78,0.44,0.5,0.25,0.55,0.33,0.89,0.25,0.55,0.72,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.78,0.28,0.67,0.72,0.72,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(30mcg IM weekly) treated MS patients. miRNA expression in </text>
   <text y="605.077" x="310.016,314.012,318.008,320.51,323.012,326.513,328.763,331.031,337.529,341.525,345.026,347.276,349.544,352.046,356.042,359.543,362.045,366.041,370.541,372.791,375.059,379.559,384.059,386.309,388.577,395.579,398.081,404.084,410.582,416.585,418.835,421.103,425.099,428.096,431.093,435.089,439.589,443.09,445.34,447.608,450.605,455.105,457.607,460.109,464.609,471.107,475.103,479.603,481.853,484.121,488.621,493.121,495.371,497.639,502.139,506.135,508.637,511.139,515.639,519.635,522.137,524.639,529.139,533.639,535.889,538.157,542.657,545.654" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.28,0.67,0.72,0.72,0.25,0.55,0.44,0.33,0.33,0.44,0.5,0.39,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells was tested by miRNA arrays followed by validation of </text>
   <text y="616.075" x="310.016,313.517,317.513,320.015,324.011,328.007,330.509,334.505,339.005,341.255,343.946,350.948,353.45,359.453,365.951,372.449,375.95,378.2,380.891,385.391,388.892,391.394,395.894,400.394,402.644,405.335,407.837,412.337,416.837,419.339,423.839,426.341,430.841,435.341,439.337,441.839,444.089,446.78,452.243,456.914,459.911,464.411,469.415,475.418,481.421,483.671,486.362,490.358,493.859,497.36,501.356,505.856,509.357,511.607" svgx:width="0.39,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.78,0.28,0.67,0.72,0.72,0.39,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.67,0.61,0.33,0.5,0.56,0.67,0.67,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">selected miRNAs using individual RT-qPCR assays. </text>
   <text y="616.075" x="516.548,519.545,524.045,526.295,528.986,532.982,535.484,537.986,541.154" svgx:width="0.33,0.5,0.25,0.55,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">In vitro</text>
   <text y="616.075" x="545.654" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="627.073" x="310.016,314.012,318.512,323.012,327.008,330.005,332.507,339.509,343.505,348.005,350.507,354.008,356.717,363.215,367.211,370.208,374.204,376.913,380.909,385.409,389.909,394.409,398.909,402.905,405.407,409.403,413.903,416.612,419.114,423.614,426.323,430.823,434.819,437.321,439.823,444.323,448.319,450.821,454.817,457.526,460.028,464.528,468.524,471.233,473.735,478.235,482.735,487.235,491.231,493.733,496.235,500.735,505.235,507.944,512.444,515.441,518.15,525.152,527.654,533.657,536.654,541.154,545.654" svgx:width="0.44,0.5,0.5,0.44,0.33,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.78,0.28,0.67,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">experiments were conducted to validate the induction of miR-21 </text>
   <text y="638.071" x="310.016,314.516,319.016,321.266,324.254,327.251,331.247,335.243,339.743,346.745,351.245,353.747,358.247,362.243,366.743,369.245,371.495,374.483,377.48,382.484,388.982,391.979,396.479,400.475,402.977,406.973,409.223,412.211,414.713,419.213,421.463,424.451,428.951,433.451,440.453,444.449,448.949,451.199,454.187,461.189,465.689,470.189,474.689,478.685,483.185,485.687,489.683,493.184,495.434,497.684,500.51,505.694,508.691,512.687,517.187,520.688,523.685,527.681,531.677,534.179,536.681,541.181,545.681" svgx:width="0.5,0.5,0.25,0.55,0.33,0.44,0.44,0.5,0.78,0.5,0.28,0.5,0.44,0.5,0.28,0.25,0.55,0.33,0.56,0.72,0.33,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.78,0.44,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.61,0.33,0.44,0.5,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">by recombinant IFN-beta in human monocytes. Transfection </text>
   <text y="649.069" x="310.016,314.012,318.512,323.012,327.008,330.005,332.507,339.509,343.505,348.005,350.507,354.008,356.258,357.59,364.088,366.59,369.092,373.592,375.842,377.174,384.176,386.678,392.681,399.179,405.182,407.432,408.764,415.766,418.268,425.27,427.772,431.768,435.269,437.519,438.851,445.349,449.345,452.342,456.338,458.588,459.92,464.42,468.416,471.413,474.41,478.91,481.907,488.909,492.905,497.405,499.655,500.987,503.489,507.989,510.239,511.571,515.072,517.574,522.074,526.574,531.074,533.324,534.656,537.158,541.658,545.654" svgx:width="0.44,0.5,0.5,0.44,0.33,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.78,0.28,0.67,0.72,0.72,0.25,0.55,0.78,0.28,0.78,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">experiments with miRNA mimics were performed to study the </text>
   <text y="660.067" x="310.016,314.012,316.847,319.844,323.84,327.836,330.338,332.588,337.088,340.085,342.335,349.337,351.839,357.842,360.839,365.339,369.839,372.089,376.589,381.089,385.085,387.902,390.899,394.895,399.395,403.895,406.892,410.888,414.389,417.89,420.392,424.892,429.392,431.642,436.142,440.642,442.892,446.888,451.388,453.89,458.39,462.89,465.392,469.892,473.888,476.138,480.134,484.634,489.134,492.131,496.127,499.628,503.129,505.631,510.131,514.631" svgx:width="0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.78,0.28,0.67,0.33,0.5,0.5,0.25,0.5,0.5,0.44,0.33,0.33,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">effect of miR-21 over-expression on cytokine expression.</text>
   <text y="671.065" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="671.065" x="343.352,351.353,353.855,359.858,362.855,367.355,371.855,374.195,378.191,382.691,387.191,390.188,394.184,397.685,401.186,403.688,408.188,412.688,415.028,421.526,425.522,429.023,431.363,433.865,438.365,442.361,445.358,449.354,453.35,456.851,460.847,465.347,467.687,470.189,474.689,477.029,484.031,488.531,493.031,497.531,501.527,506.027,508.529,512.525,516.026,518.366,522.866,525.863,528.203,531.2,536.204,542.702" svgx:width="0.89,0.28,0.67,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.33,0.56,0.72,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MiR-21 expression was increased in monocytes of IFN-</text>
   <text y="682.063" x="310.016,314.516,318.512,321.014,325.01,327.125,329.627,332.624,336.62,340.616,343.118,347.114,351.614,353.729,358.229,362.225,364.727,367.229,371.225,375.725,378.227,381.728,383.843,386.84,394.841,398.837,402.833,407.333,409.448,414.389,416.504,421.508,427.007,435.008,437.123,442.199,444.314,448.814,451.064,455.564,460.064,464.564,466.679,471.62,473.735,478.235,480.485,484.985,489.485,493.985,496.1,499.097,503.093,505.595,509.591,512.093,514.595,519.095,523.091,525.197,529.697,534.197,536.699,539.201,542.702,545.699" svgx:width="0.5,0.44,0.28,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.89,0.44,0.44,0.5,0.25,0.55,0.25,0.56,0.61,0.89,0.25,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.25,0.55,0.25,0.5,0.25,0.5,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.5,0.28,0.28,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">beta treated patients (Mean ± SEM = 3.592 ± 0.778 relative units) </text>
   <text y="693.061" x="310.016,314.012,318.512,325.514,330.014,334.01,337.007,341.003,345.503,347.753,351.209,353.711,358.211,360.461,363.917,368.417,372.413,376.409,378.911,381.413,385.913,390.413,392.663,396.119,400.619,405.119,409.619,414.119,417.116,420.617,422.867,426.323,429.32,433.82,436.07,440.57,445.07,449.57,451.82,455.276,460.217,462.467,465.923,470.423,472.673,477.173,481.673,486.173,488.423,490.673,494.129,498.629,503.705,508.205,510.455,514.955,519.455,523.955,526.952,529.202,532.658,536.654,541.154,545.654" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.39,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.5,0.25,0.55,0.55,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">compared to healthy donors (1.090 ± 0.325, p=0.012) and </text>
   <text y="704.059" x="310.016,314.516,319.016,321.518,324.515,328.511,332.507,335.009,339.005,343.505,345.755,346.511,351.011,355.007,357.509,360.011,364.007,368.507,371.009,374.51,376.76,377.516,380.513,385.013,387.263,391.763,396.263,400.763,403.013,403.769,408.71,410.96,411.716,416.216,418.466,422.966,427.466,431.966,434.216,436.466,437.222,441.722,446.798,451.298,453.548,458.048,462.548,467.048,471.548,474.545,476.795,479.639,485.138,489.638,493.634,495.884,496.64,500.636,505.136,509.636,512.633,516.629,520.13,523.631,526.133,530.633,535.133,537.383,538.139,542.639,545.636" svgx:width="0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.5,0.25,0.55,0.55,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">untreated patients (1.248 ± 0.302, p=0.0139). The expression of </text>
   <text y="715.057" x="310.016,313.013,318.512,321.509,326.009,330.509,334.505,336.755,338.366,341.363,345.863,350.363,354.863,357.86,360.11,362.36,363.971,366.473,370.973,374.969,377.219,378.83,382.331,386.831,390.827,394.823,397.325,400.322,402.824,406.82,409.07,410.681,413.183,417.179,420.014,424.514,428.51,431.012,433.262,434.873,437.87,442.37,445.367,447.617,449.228,456.23,458.732,464.735,467.732,472.232,476.732,478.982,481.232,482.843,489.341,493.337,496.838,499.088,500.699,504.2,506.702,511.202,515.702,518.204,521.201,523.703,527.699,531.695,536.195,538.697,541.199,545.699" svgx:width="0.33,0.61,0.33,0.5,0.5,0.44,0.25,0.55,0.33,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.78,0.28,0.67,0.33,0.5,0.5,0.25,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IL-12a (p35), the specific target for miR-21, was significantly </text>
   <text y="726.055" x="310.016,314.516,318.512,322.508,325.505,329.501,333.497,336.998,340.994,345.494,347.33,349.832,354.332,356.168,359.165,364.169,370.667,373.664,378.164,382.16,384.662,388.658,390.494,392.996,395.993,399.989,403.985,406.487,410.483,414.983,416.819,421.319,425.315,427.817,430.319,434.315,438.815,441.317,444.818,446.654,450.65,455.15,462.152,466.652,470.648,473.645,477.641,482.141,483.977,486.479,490.979,492.815,497.315,501.311,505.307,507.809,510.311,514.811,519.311,521.147,525.647,530.147,534.647,539.147,542.144,545.645" svgx:width="0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.33,0.56,0.72,0.33,0.5,0.44,0.28,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">decreased in IFN-beta treated patients compared to healthy donors </text>
  </g>
 </g>
</svg>
